Gabapentin NDC 42385-973

NDC codes

FDA NDC Directory

Product NDC (as listed)42385-973Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42385-0973Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42385-973-01	42385097301	100 CAPSULE in 1 BOTTLE (42385-973-01)Marketed from May 13, 2023
42385-973-05	42385097305	500 CAPSULE in 1 BOTTLE (42385-973-05)Marketed from May 13, 2023
42385-973-11	42385097311	1000 CAPSULE in 1 BOTTLE (42385-973-11)Marketed from May 13, 2023
42385-973-30	42385097330	30 CAPSULE in 1 BOTTLE (42385-973-30)Marketed from May 13, 2023
42385-973-72	42385097372	10 BLISTER PACK in 1 CARTON (42385-973-72) / 10 CAPSULE in 1 BLISTER PACKMarketed from May 13, 2023
42385-973-90	42385097390	90 CAPSULE in 1 BOTTLE (42385-973-90)Marketed from May 13, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Laurus Labs Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217546
Marketing start: May 13, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 42385-973_5fd82a02-46ac-4312-a008-fa17e5cd3ffdSPL ID 5fd82a02-46ac-4312-a008-fa17e5cd3ffdSPL set ID 07aa1bcc-df05-44fa-92d4-63894e0e6cd6RxCUI 310430, 310431, 310432, 310433, 310434UNII 6CW7F3G59XUPC 0342385980301

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442385097301 followed by a unit qualifier and the quantity

Package 42385-0973-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2026.

Indications (excerpt from the label)

Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: • Postherpetic neuralgia in adults ( 1 ) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217546

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217546
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Laurus Labs Limited	42385-972
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Laurus Labs Limited	42385-974